The Impact of Right Ventricular Function on Left Ventricular Mechanical Circulatory Support - Scorecard - MDSpire

The Impact of Right Ventricular Function on Left Ventricular Mechanical Circulatory Support

  • By

  • Bailey, James

  • March 6, 2026

  • 0 min

Share

Clinical Scorecard: The Role of Right Ventricular Performance in Supporting Left Ventricular Mechanical Circulation

At a Glance

CategoryDetail
ConditionHeart failure requiring mechanical support
Key MechanismsDependence on native right heart function for LVAD efficacy
Target PopulationPatients requiring left ventricular assist devices (LVADs)
Care SettingCardiac surgery and critical care

Key Highlights

  • LVADs are used as destination therapy and bridges to transplantation.
  • Right ventricular function is critical for optimal LVAD performance.
  • Assessment of right ventricular function is essential in LVAD management.
  • Strategies exist to mitigate the impact of right ventricular dysfunction.

Guideline-Based Recommendations

Diagnosis

  • Assess right ventricular function in patients considered for LVAD.

Management

  • Utilize HeartMate III and Impella devices based on patient needs.

Monitoring & Follow-up

  • Regularly evaluate right ventricular performance in LVAD patients.

Risks

  • Right ventricular dysfunction can adversely affect LVAD outcomes.

Patient & Prescribing Data

Patients with advanced heart failure requiring mechanical support.

LVADs are effective but require careful management of right heart function.

Clinical Best Practices

  • Incorporate right ventricular assessment in pre-LVAD evaluation.
  • Monitor hemodynamics closely post-LVAD implantation.

Related Resources & Content

    Original Source(s)

    The Impact of Right Ventricular Function on Left Ventricular Mechanical Circulatory Support

    • by Bailey, James

    • March 6, 2026

    Related Content

    Ensitrelvir Reduced COVID After Household Exposure

    In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

    FDA Approves Baxdrostat for Resistant Hypertension

    Phase 3 findings support the oral therapy in adults with persistent blood pressure elevation despite multidrug treatment.

    Impact of Previous Cardiac Surgery on Outcomes After Tricuspid Valve Transcatheter Edge-to-Edge Repair: Insights from EuroTR